Skip to content

High rate of liver fibrosis progression in HIV-positive patients, but signs that earlier initiation of antiretrovirals protective

Treatment breaks lead to fibrosis in HIV/HCV-co-infected patients

Atazanavir safe and effective for HIV/HCV patients with cirrhosis

Good survival rates for HIV/HCV-coinfected patients with compensated cirrhosis

Good outcomes among HIV-positive patients having a liver transplant due to cancer

Fatty liver disease associated with cardiovascular risk in patients with HIV

Detectable viral load, hepatitis C and cirrhosis risk factors for thrombocytopenia for patients with HIV

Sustained response to interferon improves fibrosis in HIV/HCV co-infected patients

Continuous antiretroviral therapy improves survival in HIV/hepatitis C co-infected patients with liver cirrhosis